VI 



CONTRIBUTORS 



E. L. R. Stok«tai) (89-121, 124-202) 

 Lederle Laboratories 

 Pearl River, New York 



Peter A. Tavormina (2-12, 13-52, 62-85) 

 Sharp and Dohme 

 West Point, Pennsylvania 



W. W. Umbreit (239-242) 

 Merck Therapeutic Institute 

 Rahway, New Jersey 



Klaus R. Unna (290-293, 466-471) 

 Department of Pharmacology 

 Medical School 

 University of Illinois 

 Chicago, Illinois 



Lemuel D. Wright (2-12, 13-52, 62-85) 

 Director of Research in Microbiolog- 

 ical Chemistry 

 Research Division 

 Sharp and Dohme 

 West Point, Pennsylvania 



TheodorWagner-Jauregg (301-333) 

 Medical Division 

 Army Medical Center 

 Edgewood, Maryland 



H. M. WuEST (12-13, 409-425) 

 137 Summit Avenue 

 Montclair, New Jersey 



